Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive

Background/Aims Anti-mitochondrial M2 antibody (AMA-M2) is a specific marker for primary biliary cholangitis (PBC) and it could be also present in non-PBC individuals. Methods A total of 72,173 Chinese health check-up individuals tested AMA-M2, of which non-PBC AMA-M2 positive individuals were perfo...

Full description

Saved in:
Bibliographic Details
Main Authors: Haolong Li, Song Liu, Xu Wang, Xinxin Feng, Siyu Wang, Yanli Zhang, Fengchun Zhang, Li Wang, Tengda Xu, Yongzhe Li
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2025-04-01
Series:Clinical and Molecular Hepatology
Subjects:
Online Access:http://e-cmh.org/upload/pdf/cmh-2024-0416.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850196972847235072
author Haolong Li
Song Liu
Xu Wang
Xinxin Feng
Siyu Wang
Yanli Zhang
Fengchun Zhang
Li Wang
Tengda Xu
Yongzhe Li
author_facet Haolong Li
Song Liu
Xu Wang
Xinxin Feng
Siyu Wang
Yanli Zhang
Fengchun Zhang
Li Wang
Tengda Xu
Yongzhe Li
author_sort Haolong Li
collection DOAJ
description Background/Aims Anti-mitochondrial M2 antibody (AMA-M2) is a specific marker for primary biliary cholangitis (PBC) and it could be also present in non-PBC individuals. Methods A total of 72,173 Chinese health check-up individuals tested AMA-M2, of which non-PBC AMA-M2 positive individuals were performed follow-up. Baseline data of both clinical characteristics and laboratory examinations were collected in all AMA-M2-positive individuals. Least absolute shrinkage and selection operator (LASSO) regression was performed to investigate the potential variables for developing PBC. Results A total of 2,333 individuals were positive with AMA-M2. Eighty-two individuals had a medical history of PBC or fulfilled the diagnostic criteria of PBC at baseline, and 2,076 individuals were non-PBC. After a median follow-up of 6.6 years, 0.6% developed PBC, with an accumulative 5-year incidence rate of 0.5%. LASSO regression showed that levels of alkaline phosphatase (ALP), gamma-glutamyl transpeptidase (GGT), immunoglobulin M (IgM), eosinophilia proportion (EOS%), gamma globulin percentage, and hemoglobin (HGB) were potential variables for developing PBC. Multivariate Cox regression is used to construct a predictive model based on 7 selected variables, and time-dependent receiver operating characteristic analysis showed that the area under the curve of the prediction model at 3, 5, and 10 years were, respectively, 1.000, 0.875, and 0.917. Conclusions This study offers insights into the onset of PBC among individuals who tested positive for AMA-M2 during routine health check-ups. The prediction model based on ALP, GGT, IgM, EOS%, gamma globulin percentage, HGB, and sex has a certain predictive ability for the occurrence of PBC in this population.
format Article
id doaj-art-2ee60b7d4dd6422fb4b25d8800441306
institution OA Journals
issn 2287-2728
2287-285X
language English
publishDate 2025-04-01
publisher Korean Association for the Study of the Liver
record_format Article
series Clinical and Molecular Hepatology
spelling doaj-art-2ee60b7d4dd6422fb4b25d88004413062025-08-20T02:13:19ZengKorean Association for the Study of the LiverClinical and Molecular Hepatology2287-27282287-285X2025-04-0131247448810.3350/cmh.2024.04162130Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positiveHaolong Li0Song Liu1Xu Wang2Xinxin Feng3Siyu Wang4Yanli Zhang5Fengchun Zhang6Li Wang7Tengda Xu8Yongzhe Li9 Department of Clinical Laboratory, State key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China Center for Bioinformatics, National Infrastructures for Translational Medicine, Institute of Clinical Medicine & Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China Department of Rheumatology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China Department of Clinical Laboratory, State key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China Department of Clinical Laboratory, State key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China Department of Health Management, Peking Union Medical College Hospital, Beijing, China Department of Rheumatology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China Department of Rheumatology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China Department of Health Management, Peking Union Medical College Hospital, Beijing, China Department of Clinical Laboratory, State key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, ChinaBackground/Aims Anti-mitochondrial M2 antibody (AMA-M2) is a specific marker for primary biliary cholangitis (PBC) and it could be also present in non-PBC individuals. Methods A total of 72,173 Chinese health check-up individuals tested AMA-M2, of which non-PBC AMA-M2 positive individuals were performed follow-up. Baseline data of both clinical characteristics and laboratory examinations were collected in all AMA-M2-positive individuals. Least absolute shrinkage and selection operator (LASSO) regression was performed to investigate the potential variables for developing PBC. Results A total of 2,333 individuals were positive with AMA-M2. Eighty-two individuals had a medical history of PBC or fulfilled the diagnostic criteria of PBC at baseline, and 2,076 individuals were non-PBC. After a median follow-up of 6.6 years, 0.6% developed PBC, with an accumulative 5-year incidence rate of 0.5%. LASSO regression showed that levels of alkaline phosphatase (ALP), gamma-glutamyl transpeptidase (GGT), immunoglobulin M (IgM), eosinophilia proportion (EOS%), gamma globulin percentage, and hemoglobin (HGB) were potential variables for developing PBC. Multivariate Cox regression is used to construct a predictive model based on 7 selected variables, and time-dependent receiver operating characteristic analysis showed that the area under the curve of the prediction model at 3, 5, and 10 years were, respectively, 1.000, 0.875, and 0.917. Conclusions This study offers insights into the onset of PBC among individuals who tested positive for AMA-M2 during routine health check-ups. The prediction model based on ALP, GGT, IgM, EOS%, gamma globulin percentage, HGB, and sex has a certain predictive ability for the occurrence of PBC in this population.http://e-cmh.org/upload/pdf/cmh-2024-0416.pdfprimary biliary cholangitisanti-mitochondrial m2 antibodyhealth check-up
spellingShingle Haolong Li
Song Liu
Xu Wang
Xinxin Feng
Siyu Wang
Yanli Zhang
Fengchun Zhang
Li Wang
Tengda Xu
Yongzhe Li
Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive
Clinical and Molecular Hepatology
primary biliary cholangitis
anti-mitochondrial m2 antibody
health check-up
title Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive
title_full Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive
title_fullStr Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive
title_full_unstemmed Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive
title_short Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive
title_sort prediction of primary biliary cholangitis among health check up population with anti mitochondrial m2 antibody positive
topic primary biliary cholangitis
anti-mitochondrial m2 antibody
health check-up
url http://e-cmh.org/upload/pdf/cmh-2024-0416.pdf
work_keys_str_mv AT haolongli predictionofprimarybiliarycholangitisamonghealthcheckuppopulationwithantimitochondrialm2antibodypositive
AT songliu predictionofprimarybiliarycholangitisamonghealthcheckuppopulationwithantimitochondrialm2antibodypositive
AT xuwang predictionofprimarybiliarycholangitisamonghealthcheckuppopulationwithantimitochondrialm2antibodypositive
AT xinxinfeng predictionofprimarybiliarycholangitisamonghealthcheckuppopulationwithantimitochondrialm2antibodypositive
AT siyuwang predictionofprimarybiliarycholangitisamonghealthcheckuppopulationwithantimitochondrialm2antibodypositive
AT yanlizhang predictionofprimarybiliarycholangitisamonghealthcheckuppopulationwithantimitochondrialm2antibodypositive
AT fengchunzhang predictionofprimarybiliarycholangitisamonghealthcheckuppopulationwithantimitochondrialm2antibodypositive
AT liwang predictionofprimarybiliarycholangitisamonghealthcheckuppopulationwithantimitochondrialm2antibodypositive
AT tengdaxu predictionofprimarybiliarycholangitisamonghealthcheckuppopulationwithantimitochondrialm2antibodypositive
AT yongzheli predictionofprimarybiliarycholangitisamonghealthcheckuppopulationwithantimitochondrialm2antibodypositive